M. Perkus

发表

The complete DNA sequence of vaccinia virus.

S. Goebel, G. P. Johnson, M. Perkus, 1990, Virology.

Recombinant vaccinia virus: immunization against multiple pathogens

M. Perkus, E. Paoletti, A. Piccini, 1985 .

Recombinant vaccinia virus: immunization against multiple pathogens.

M. Perkus, E. Paoletti, A. Piccini, 1986, Science.

Insertion and deletion mutants of vaccinia virus.

M. Perkus, E. Paoletti, D. Panicali, 1986, Virology.

DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice

M. Perkus, P. Pancholi, A. Prince, 2003, Journal of Virology.

Highly attenuated poxvirus vectors.

M. Perkus, E. Paoletti, W. Cox, 1992, AIDS research and human retroviruses.

DNA prime/canarypox boost—based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

M. Perkus, P. Pancholi, A. Prince, 2001, Hepatology.

Host-range restriction of vaccinia virus E3L-specific deletion mutants

M. Perkus, E. Paoletti, J. Tartaglia, 2004, Virus Genes.

3.6. Recombinant Virus as Vaccination Carrier of Heterologous Antigens

M. Perkus, E. Paoletti, 1996 .

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.

M. Perkus, P. Pancholi, A. Prince, 2000, The Journal of infectious diseases.

Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC).

M. Perkus, A. Prince, B. Brotman, 1998, Journal of immunological methods.

Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.

M. Perkus, E. Paoletti, K. Steimer, 1989, AIDS.

Mapping the genes in the terminal redundancy of bacteriophage SPO1 with restriction endonucleases

M. Perkus, D. Shub, 1985, Journal of virology.

Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.

M. Perkus, L. Tobler, A. Prince, 2003, Virology.

NYVAC: a highly attenuated strain of vaccinia virus.

M. Perkus, S. Davis, E. Paoletti, 1992, Virology.

Vaccinia virus host range genes.

S. Goebel, G. P. Johnson, M. Perkus, 1990, Virology.

Vaccinia virus encodes a protein with similarity to glutaredoxins.

S. Goebel, G. P. Johnson, M. Perkus, 1991, Virology.

Deletion of 55 open reading frames from the termini of vaccinia virus.

S. Goebel, G. P. Johnson, M. Perkus, 1991, Virology.

Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity

S. Goebel, M. Perkus, E. Paoletti, 1990, Journal of virology.

Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.

M. Perkus, E. Paoletti, L. Aurelian, 1989, The Journal of infectious diseases.

Expression of herpes simplex virus glycoprotein D on antigen presenting cells infected with vaccinia recombinants and protective immunity

M. Perkus, E. Paoletti, L. Aurelian, 1988, Bioscience reports.

Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.

M. Perkus, E. Paoletti, L. Aurelian, 1987, The Journal of infectious diseases.

Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene

M. Perkus, E. Paoletti, J. Tartaglia, 1995, Journal of virology.

Optimization of recombinant vaccinia-based ELISPOT assay.

M. Perkus, A. Prince, A. Talal, 2003, Journal of immunological methods.

Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants

M. Perkus, E. Paoletti, J. Tartaglia, 1992, Journal of virology.

Vaccinia virus as an expression vector.

M. Perkus, E. Paoletti, A. Piccini, 1987, Methods in enzymology.

Cloning and expression of foreign genes in vaccinia virus, using a host range selection system

M. Perkus, E. Paoletti, K. Limbach, 1989, Journal of virology.

Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals

S. Goebel, M. Perkus, S. Davis, 1989, Journal of virology.

Methodology of using vaccinia virus to express foreign genes in tissue culture

M. Perkus, E. Paoletti, Jill Taylor, 1993 .

Response of dairy calves to vaccinia viruses that express foreign genes

M. Perkus, E. Paoletti, S. Mercer, 1986, Journal of clinical microbiology.

A Modern Approach to Live Vaccines: Recombinant Poxviruses

M. Perkus, E. Paoletti, S. Mercer, 1986 .

Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity.

M. Perkus, E. Paoletti, L. Aurelian, 1989, The Journal of general virology.

Live recombinant vaccines using genetically engineered vaccinia virus.

M. Perkus, E. Paoletti, A. Piccini, 1985, Antiviral research.

in HLA-A 2 . 1-Transgenic Mice Recombinant HCV-Vaccinia Virus Infection Responses and Protection from Canarypox Virus Boosting Induces Immune by HCV DNA Priming-Recombinant Immunization ( HCV ) Polycistronic Genes or DNA Immunization with Hepatitis C Virus

M. Perkus, P. Pancholi, A. Prince, 2002 .

Live Attenuated Vaccinia and Other Poxviruses as Delivery Systems: Public Health Issues

M. Perkus, E. Paoletti, Jill Taylor, 1995, Annals of the New York Academy of Sciences.